Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Depression 5 Depressive Disorder, Major 3 Polycystic Ovary Syndrome 2 Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Neoplasms 1 Hot Flashes 1 Head and Neck Neoplasms 1 Glioma 1 Gallbladder Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1 ENT Cancer 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Bile Duct Neoplasms 1 Behavior, Addictive 1 Asthma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × ENT Cancer × Escitalopram × Clear all

NCT02246244 2016-06-10

TADDOR

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

ENT Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡